DIARYpro Available on Patients' Smartphones - Delivering Reliability while Reducing Trial Costs
ERT, a leading global solution provider for high-quality patient safety and efficacy endpoint data collection, today announced an expansion to its comprehensive suite of electronic Clinical Outcome Assessment (eCOA) data collection solutions for use in clinical trials. With this expansion, clinical trial sponsors can improve trial efficiencies while reliably collecting important eCOA data via patients’ personal Apple® (iOS) or Android™ phones and tablets.
An extension of ERT’s flagship DIARYpro® solution, the Bring Your Own Device (BYOD) option is based on over 25 years of scientifically and regulatory-proven COA data collection experience. This native mobile application enables trial sponsors to acquire high-quality eCOA data while eliminating the cost and time associated with purchasing, shipping, and managing a global fleet of dedicated eCOA devices. In addition, ERT’s BYOD solution ensures that assessments are presented consistently across different device types and screen resolutions.
“DIARYpro has set the industry standard for high data quality and reliability,” said Bob Young, EVP and Product Line Executive, eCOA at ERT. “In expanding the solution to include a BYOD option, we conducted significant research among global clinical trial sponsors to ensure it not only meets these standards, but also offers valuable features that will streamline the eCOA data collection process.”
Unlike other mobile applications that run within web browsers and require a live internet connection, ERT’s BYOD solution allows fully-offline operation for when data must be entered during strict time windows, regardless of internet connectivity. Further, on-device reminders to begin or continue assessments are not dependent on any external email or text server, and these notifications blend naturally into smartphone users’ daily lives, enhancing compliance.
Having supported over 1,200 COA global clinical trials to date, ERT’s solutions and services are routinely relied upon by biopharmaceutical researchers for capturing important patient data during clinical development. For more information on ERT’s comprehensive suite of eCOA data collection solutions, including BYOD, visit www.ert.com/eCOA.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Regulatory Compliance With eCOAs
April 26th 2024In the fourth and final part of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA discusses how the regulatory stance on electronic clinical outcome assessments has changed over the years and what it could look like in the future.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.